 |
市場調查報告書
商品編碼
1290602
皮下給藥市場：按可用性、按適應症（、按輸送系統、按地區-規模、份額、展望、機會分析，2023-2030Subcutaneous Drug Delivery Market, By Usability, Disease Indication(Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, & Others), Delivery System, & Region-Size, Share, Outlook, & Opportunity Analysis, 2023-2030 |
||||||
價格
簡介目錄
預充式註射器和自動注射器的技術創新和開發正在促進市場的增長。 例如，德國初級包裝製造商Gerresheimer於2020年6月宣布推出適用於生物技術生產的活性成分的完美初級包裝，該包裝不含鎢，完美地消除了金屬污染的可能性，並推出了Lure Lock Gx RTF注射器。
此外，2022 年 3 月，醫療設備製造商 YpsoMed 開發了 YpsoMate SmartPilot，這是其專有 YpsoMate 筆的可重複使用附件，可簡化兩步注射過程。 該設備配備了傳感器和內存，通過將其連接到應用程序，可以顯示注射時間和劑量。 該筆向用戶提供音頻和視覺反饋。 該應用程序還可以提醒用戶何時注射胰島素。
市場動態
監管機構的產品批准預計將在預測期內推動市場增長。 例如，2023 年 3 月 6 日，其全球生物仿製藥公司 Coherus BioSciences, Inc. 宣布美國食品和藥物管理局 (FDA) 批准推出 UDENYCA (pegfilgrastim-cbqv) 單劑量預充式自動注射器。它做了。 UDENYCA 自動注射器採用流線型且用戶友好的設計，適合辦公室和家庭護理使用。
本研究的主要特點
- 本報告對全球皮下給藥市場進行了深入分析，提供了以 2022 年為基準年的預測期（2023-2030 年）的市場規模和復合年增長率。
- 它還闡明了各個細分市場的潛在收入機會，並概述了該市場有吸引力的投資主張矩陣。
- 它還提供了有關市場驅動因素、限制因素、機遇、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
- 根據公司概況、業績、產品組合、市場佔有率、分銷策略、主要發展、戰略和未來計劃等參數，介紹全球皮下給藥市場的主要參與者。
- 本研究涵蓋的主要公司包括 Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Inc., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, Merck & Co., Inc., Insulet Corporation, West Pharmaceutical Services, Inc Gerresheimer AG 和其他知名關鍵參與者。
- 從本報告中獲得的見解將使企業營銷人員和管理層能夠就未來的產品發布、技術升級、市場擴張和營銷策略做出明智的決策。
- 《全球皮下給藥市場報告》面向該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和財務分析師。
- 利益相關者可以通過用於分析全球皮下給藥市場的各種策略矩陣來促進決策。
內容
第 1 章目的和先決條件
- 調查目的
- 先決條件
- 縮寫
第 2 章市場展望
- 報告摘要
- 市場定義和範圍
- 執行摘要
- 市場概況：按可用性分類
- 市場概況：按跡象分類
- 市場概況：按交付系統分類
- 市場概況：按分銷渠道劃分
- 市場概況：按地區
- 連貫的機會地圖 (COM)
第 3 章市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 市場機會
- 影響分析
- 最近的產品公告
- 合併、收購、聯合研究
- 產品發布
- 監管場景
- PEST分析
第 4 章全球皮下給藥市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 經濟影響
- COVID-19 的流行病學
- 對供需的影響
第 5 章全球皮下給藥市場：按可用性劃分，2017-2030
- 一次性
- 可重複使用
第 6 章全球皮下給藥市場：按適應症分類，2017-2030
- 自身免疫性疾病
- 神經系統疾病
- 腫瘤疾病
- 荷爾蒙失調
- 過敏和傳染病
- 眼科疾病
- 其他
第 7 章全球皮下給藥市場：按給藥系統劃分，2017-2030 年
- 預灌封注射器
- 自動注射器
- 筆式注射器
- 一次性
- 其他（泵等）
第 8 章全球皮下給藥市場：按分銷渠道劃分，2017-2030 年
- 醫院藥房
- 零售藥店
- 網上藥店
第 9 章2017-2030年按地區劃分的全球皮下給藥市場
- 北美
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲地區
- 歐洲
- 英國
- 德國
- 意大利
- 法國
- 西班牙
- 俄羅斯
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 東盟
- 澳大利亞
- 韓國
- 亞太地區其他地區
- 中東
- 海灣合作委員會國家
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中非
- 南非
第 10 章競爭格局
- 公司簡介
- Becton Dickinson and Company
- Novo Nordisk A/S
- Johnson & Johnson.
- Novartis International AG
- Amgen, Inc
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche AG.
- Consort Medical plc.
- LaVision Biotec GmbH
- Eli Lilly and Company
- Merck & Co., Inc.
- Insulet Corporation
- West Pharmaceutical Services, Inc.
- Gerresheimer AG.
第 11 章部分
- 參考文獻
- 調查方法
簡介目錄
Product Code: CMI2933
Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer, German manufacturer of primary packaging introduced metal-free Lure Lock Gx RTF Syringe in June 2020, without tungsten to create the perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal.
Moreover, in March 2022, YpsoMed, medical device companies developed YpsoMate SmartPilot, a reusable attachment to its proprietary YpsoMate pen, which is designed for an easy two-step injection process. The device has a sensor and memory, which is connected to an app, which displays injection timing and doses. The pen provides audio and visual feedback to users. The app can also remind users when it is time to inject the insulin.
Market Dynamics
Product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on March 6, 2023, Coherus BioSciences, Inc, its global biosimilar company, announced U.S. Food and Drug Administration (FDA) approved a single-dose, prefilled auto injector presentation of UDENYCA (pegfilgrastim-cbqv). The UDENYCA autoinjector has a streamlined, easy-to-use design for use in both in-office and at-home settings of care.
Key features of the study:
- This report provides in-depth analysis of the global subcutaneous drug delivery market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global subcutaneous drug delivery market based on the following parameters-company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Inc., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, Merck & Co., Inc., Insulet Corporation, West Pharmaceutical Services, Inc Gerresheimer AG and other prominent key players.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- Global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market
Detailed Segmentation:
- Global Subcutaneous Drug Delivery Market, Usability
- Disposable
- Reusable
- Global Subcutaneous Drug Delivery Market, Disease Indication
- Auto-immune Disorders
- Neurological Disorders
- Oncology Disorders
- Hormonal Disorders
- Allergy & Infectious Disorders
- Ophthalmic Disorders
- Others
- Global Subcutaneous Drug Delivery Market, Delivery System
- Prefilled Syringes
- Autoinjector
- Spring Type
- Motorized Type
- Wearable Type
- Pen Injectors
- Disposable
- Reusable
- Syringes (Injector)
- Others (pump, etc.)
- Global Subcutaneous Drug Delivery Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Subcutaneous Drug Delivery Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Becton Dickinson and Company,
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novo Nordisk A/S,
- Johnson & Johnson
- Novartis International AG
- Amgen, Inc.
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche AG.,
- Consort Medical plc,
- Eli Lilly and Company
- Merck & Co., Inc.
- Insulet Corporation,
- West Pharmaceutical Services, Inc.
- Gerresheimer AG
- Becton Dickinson and Company,
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Usability
- Market Snapshot, By Disease Indication
- Market Snapshot, By Delivery System
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Merger, Acquisition, and Collaborations
- Product Launch
- Regulatory Scenario
- PEST Analysis
4. Global Subcutaneous Drug Delivery Market- Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Subcutaneous Drug Delivery Market, By Usability, 2017-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
6. Global Subcutaneous Drug Delivery Market, By Disease Indication , 2017-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Auto-immune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Oncology Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Hormonal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Allergy & Infectious Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Ophthalmic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
7. Global Subcutaneous Drug Delivery Market, By Delivery System, 2017-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Auto injector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Pen Injectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Others (pump, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
8. Global Subcutaneous Drug Delivery Market, By Distribution Channel, 2017-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
9. Global Subcutaneous Drug Delivery Market, By Region, 2017-2030, (US$ Billion)
- Overview
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Becton Dickinson and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novo Nordisk A/S
- Johnson & Johnson.
- Novartis International AG
- Amgen, Inc
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche AG.
- Consort Medical plc.
- LaVision Biotec GmbH
- Eli Lilly and Company
- Merck & Co., Inc.
- Insulet Corporation
- West Pharmaceutical Services, Inc.
- Gerresheimer AG.
11. Section
- References
- Research Methodology
- About us and Sales Contact
